Water Safety Plan training at RIVM From 26 – 28 June 2017, Harold van den Berg (RIVM) and Giuliana Ferrero (UNESCO-IHE) conducted a training to explain the Water Safety Plan (WSP) approach of the World Health Organization (WHO) and
Water Quality Monitoring Training for project SMALL in Mozambique The project SMALL aims at supporting the development of applicable and sustainable water and sanitation provision models for small towns of Sub-Saharan Africa.
Ethiopian delegation visits RIVM A delegation from the Ethiopian Ministry of Water, Irrigation and Electricity visited RIVM on May 30th 2017. Mutual interests were discussed and also future collaborative activities.
Risk of measles outbreaks increases with decreasing vaccination coverage Vaccination coverage for vaccinations in the Dutch National Vaccination Program (NIP) decreased slightly by about half a percent for the third consecutive year.
Training on Water Safety Plans by Unesco-IHE and RIVM in Suriname The Suriname Water Company (SWM) recently started the implementation of Water Safety Plans (WSPs). The inception phase included a tailor-made training by Dr. Giuliana Ferrero (UNESCO-IHE) and Mr.
Health effects due to titanium nanoparticles in food and toothpaste cannot be excluded Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.
Tool for risk assessment of nanomaterials in cosmetics Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.
Nanotechnology increasingly used in medical devices The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.
Measles epidemic and Salmonella outbreak cost nearly six million euros The most recent measles epidemic and outbreak of Salmonella Thomson due to smoked salmon have cost 3.9 and 1.7 million euros, respectively.
Cost-effective risk assessment of nanomaterials may be feasible Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.